Expanding Research Accessibility through Translations

BJS is pleased to host translations of select journal articles by our esteemed Chinese colleagues. These translations aim to make our research more accessible to a broader audience, while fostering greater collaboration across our global community.

Please note that BJS cannot be liable for any mistranslations or errors that may have arisen as a result. However, we would be delighted to receive comments on any errors or misquotations if they occur. Should that happen, corrections would be swift and complete, ensuring the highest standards of accuracy and integrity in our publications.

Translated Articles

Volume 112, Issue 2, February 2025

• 降低左侧胰腺切除术后胰瘘发生率——探索仍在继续
  (Reducing pancreatic fistula after left-sided pancreatectomy—the search continues)

• 局部进展期食管腺癌与交界性腺癌多模式治疗的演变格局
  (The changing landscape of multimodal treatment for locally advanced oesophageal and junctional adenocarcinoma)

• 局部晚期胰腺癌 FOLFIRINOX 诱导治疗后碳水化合物抗原 19-9 (CA19-9) 的反应可确定哪些患者可从手术探查中获益：多中心观察性队列研究
  (Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study)

• 静脉性腿部溃疡脱细胞真皮同种异体移植治疗：DAVE随机对照试验
  (Decellularized dermis allograft for the treatment of venous leg ulceration: the DAVE RCT)

• pT2期直肠癌淋巴结转移风险：一项全国范围的回顾性研究
  (Risk of lymph node metastasis in pT2 rectal cancer: a nationwide retrospective analysis)

• 弹力袜避免血栓后综合征：CHAPS  随机临床试验
  (Compression hosiery to avoid post-thrombotic syndrome: CHAPS randomized clinical trial)

• 直肠癌手术：放射学路线图
  (Rectal cancer surgery: radiology roadmaps)

• 术前立体定向放疗预防高危患者行胰十二指肠切除术后胰瘘（FIBROPANC）：前瞻性多中心II期单臂试验
  (Preoperative stereotactic radiotherapy to prevent pancreatic fistula in high-risk patients undergoing pancreatoduodenectomy (FIBROPANC): prospective multicentre phase II single-arm trial)

Volume 111, Issue 9, September 2024

• 机械性肠道准备对左侧结直肠癌手术患者肠道微生物的影响：随 机临床试验
  (Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial)